Search clinical trials for: Sebetralstat

Total 6 results

KalVista Pharmaceuticals, Ltd.

Available

Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat

Hereditary Angioedema

United States
KalVista Pharmaceuticals, Ltd.

Recruiting

Safety and Effectiveness of Sebetralstat (KVD900) for Short-Term Prophylaxis Before Procedures in People With Hereditary Angioedema (KONTROL)

Hereditary Angioedema

United States
KalVista Pharmaceuticals, Ltd.

Approved for marketing

Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

Hereditary Angioedema

United States
KalVista Pharmaceuticals, Ltd.

Completed

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II (KONFIDENT-KID)

Hereditary Angioedema

United States, France, Israel, Italy, Canada, Germany, Japan
KalVista Pharmaceuticals, Ltd.

Completed

PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial

Hereditary Angioedema

United States, Bulgaria, France, Germany, Greece, Israel, Japan, Netherlands, Spain, United Kingdom, Australia, Slovakia, South Africa, New Zealand, Canada, Romania, Austria

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe